Literature DB >> 26775566

Interleukin-10 deficiency aggravates angiotensin II-induced cardiac remodeling in mice.

Woo-Young Kwon1, Hye-Na Cha1, Jung-Yoon Heo1, Jung-Hyun Choi2, Byung Ik Jang3, In-Kye Lee4, So-Young Park5.   

Abstract

AIMS: This study examined the role of interleukin (IL)-10 in angiotensin II-induced cardiac remodeling. MAIN
METHODS: Angiotensin II was infused subcutaneously (1.1mg/kg/day) for one week in IL-10 knockout and wild-type mice, after which cardiac function and hypertrophy were assessed by echocardiogram. KEY
FINDINGS: IL-10 gene expression in the heart was increased by angiotensin II infusion. Plasma levels of brain natriuretic peptide (BNP) and gene expression of BNP in the heart were increased by IL-10 deficiency or angiotensin II, and plasma BNP levels were further increased by IL-10 deficiency with angiotensin II. IL-10 deficiency increased the left ventricular dimension, whereas treatment with angiotensin II increased heart weight. Angiotensin II significantly reduced cardiac function in IL-10 knockout mice compared with wild-type mice. Gene expression of tumor necrosis factor-α and interleukin-6 was increased by IL-10 deficiency or angiotensin II infusion, and these increases were further enhanced by IL-10 deficiency with angiotensin II. Gene expression of collagen I/III and collagen III protein levels were increased by angiotensin II but not by IL-10 deficiency. Gene expression of matrix metalloproteinase2/9 was increased by IL-10 deficiency or angiotensin II, and this expression was further increased by IL-10 deficiency with angiotensin II. Akt phosphorylation was increased by IL-10 deficiency or angiotensin II and further increased by IL-10 deficiency with angiotensin II. Phosphorylation of p38 was increased by IL-10 deficiency. SIGNIFICANCE: These results suggest that IL-10 deficiency causes deterioration in cardiac functions in angiotensin II-infused mice, suggesting that IL-10 plays a protective role against angiotensin II-induced cardiac remodeling.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiotensin II; Cytokines; Heart; Interleukin-10

Mesh:

Substances:

Year:  2016        PMID: 26775566     DOI: 10.1016/j.lfs.2016.01.022

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

Review 1.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

2.  Novel Insights into the Cardioprotective Effects of Calcitriol in Myocardial Infarction.

Authors:  Simin Yang; Chunmiao Wang; Chengshao Ruan; Meiling Chen; Ran Cao; Liang Sheng; Naiying Chang; Tong Xu; Peiwen Zhao; Xuesheng Liu; Fengqin Zhu; Qingzhong Xiao; Shan Gao
Journal:  Cells       Date:  2022-05-18       Impact factor: 7.666

3.  Angiotensin II-Induced End-Organ Damage in Mice Is Attenuated by Human Exosomes and by an Exosomal Y RNA Fragment.

Authors:  Linda Cambier; Jorge F Giani; Weixin Liu; Takeshi Ijichi; Antonio K Echavez; Jackelyn Valle; Eduardo Marbán
Journal:  Hypertension       Date:  2018-06-04       Impact factor: 10.190

4.  Silencing salusin-β attenuates cardiovascular remodeling and hypertension in spontaneously hypertensive rats.

Authors:  Xing-Sheng Ren; Li Ling; Bing Zhou; Ying Han; Ye-Bo Zhou; Qi Chen; Yue-Hua Li; Yu-Ming Kang; Guo-Qing Zhu
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

Review 5.  The role of B cells in heart failure and implications for future immunomodulatory treatment strategies.

Authors:  Gerardo García-Rivas; Elena Cristina Castillo; Adrian M Gonzalez-Gil; José Luis Maravillas-Montero; Marion Brunck; Alejandro Torres-Quintanilla; Leticia Elizondo-Montemayor; Guillermo Torre-Amione
Journal:  ESC Heart Fail       Date:  2020-06-13

6.  Signaling via the Interleukin-10 Receptor Attenuates Cardiac Hypertrophy in Mice During Pressure Overload, but not Isoproterenol Infusion.

Authors:  Nicholas Stafford; Farryah Assrafally; Sukhpal Prehar; Min Zi; Ana M De Morais; Arfa Maqsood; Elizabeth J Cartwright; Werner Mueller; Delvac Oceandy
Journal:  Front Pharmacol       Date:  2020-10-30       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.